Objective
The general objective of INNOCHEM is to develop innovative chemokine-based therapeutic strategies for autoimmunity and chronic inflammation. The project is based on the scientific excellence of the applicants, which have made major recognized contributions to the field since the very beginning of chemokine discovery, and on the construction of shared technological platforms.
This will include:
- proteomics and
- transcriptional profiling for the outline of the "chemokinome" in pathophysiological conditions and identification of new antagonists;
- molecular modelling of agonist/antagonist receptor or agonist/inhibitor interaction, for pharmacology and drug design; iv) gene modified mice for target validation in autoimmune disorders.
Genetic, structural, biological, and immunopathological studies will provide a framework for the development of innovative chemokine-based therapeutic strategies. The therapeutic approaches to be investigated are innovative and not limited to conventional antagonists. These will include decoy receptors, agonist binders, and non-competitive allosteric inhibitors. In addition to academic groups, therapy-oriented research will include 3 biotech SMEs, and 3 Pharma companies. The companies involved develop complementary non-overlapping approaches to target the chemokine system with recombinant and low molecular weight molecules.
INNOCHEM is expected to conduct a "proof of principle" clinical study in volunteers in the first 18 months. The ambition of this project is to re-establish European leadership in basic and applied chemokine research by integrating academic and industrial cutting edge groups to develop innovative therapeutic strategies against autoimmunity and chronic inflammatory disorders.
Fields of science
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsproteomics
- medical and health scienceshealth sciencesinflammatory diseases
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- medical and health sciencesbasic medicinemedicinal chemistry
- medical and health sciencesbasic medicineimmunology
Call for proposal
FP6-2004-LIFESCIHEALTH-5
See other projects for this call
Funding Scheme
IP - Integrated ProjectCoordinator
ROZZANO-MILANO
Italy
See on map
Participants (28)
BELLINZONA
See on map
PARIS
See on map
PARIS
See on map
LODZ
See on map
740238 BERLIN
See on map
BERN
See on map
MUNICH
See on map
BRUSSELS
See on map
LONDON
See on map
FIRENZE
See on map
COPENHAGEN
See on map
LEUVEN
See on map
LONDON
See on map
MILANO
See on map
L'AQUILA
See on map
ALLSCHWIL
See on map
VIENNA
See on map
GENEVA
See on map
SIENA
See on map
L'AQUILA
See on map
BELO HORIZONTE MG
See on map
CARDIFF
See on map
GLASGOW
See on map
LONDON
See on map
ROMA
See on map
PLAN LES OUATES
See on map
2213 REHOVOT
See on map
MADRID
See on map